Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSPPT: Enalapril/Folic Acid for Stroke Prevention
NCT00794885Phase 4Completed
- Sponsor
- Shenzhen Ausa Pharmaceutical
- Start
- May 2008
- Primary completion
- Aug 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of folic acid in stroke, sponsored by Shenzhen Ausa Pharmaceutical. Started May 2008; status: completed.
02
Drugs
folic acid
03
Conditions
stroke
Beyond the preview
Go deeper on NCT00794885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00794885.